Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S307000, C514S311000, C514S351000, C514S357000, C514S365000, C514S374000, C514S400000, C514S406000, C514S438000, C514S469000, C514S620000, C544S215000, C544S335000, C546S146000, C546S175000, C546S300000, C546S337000, C548S205000, C548S236000, C548S238000, C548S375100, C549S077000, C549S462000, C549S493000, C564S168000
Reexamination Certificate
active
07122547
ABSTRACT:
The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.
REFERENCES:
patent: 3226394 (1965-12-01), Schipper et al.
patent: 3409668 (1968-11-01), Palazzo
patent: 4568687 (1986-02-01), Wright, Jr. et al.
patent: 5716993 (1998-02-01), Ozaki et al.
patent: 2652144 (1978-05-01), None
patent: 3406416 (1984-08-01), None
patent: 0564356 (1993-10-01), None
patent: 50157383 (1975-12-01), None
CAS printout for Wright et al. Chem. Abs. 102: 78876. (1985).
CAS printout for Kovac et al. Chem Abs. 100: 34516 (1984).
Carmellet and Jain, Angiogenesis in cancer and other diseases, Nature 407:249-257 (2000).
Database Chemabs \377Online\377 Chemical Abstracts Service, Columbus, Ohio, US Montginoul, C. et al: “Analgesic anticonvulsant and anti-inflammatory activities of IH,3H-quinazoline-2,4-diones” retrieved from STN Database accession No. 110:165551h XP002135868 & Ann. Pharm. Fr. (1989), 46(4), 223-32.
Chemical Abstracts, vol. 85, No. 3, Jul. 19, 1976 (Jul. 19, 1976) Columbus, Ohio, US: abstract No. 21433p, Noda, Kanji et al: “Quinazoline compounds” Seite 701: XP002135867 & JP 50 157383 A (Hisamitsu Pharmaceutical Co., Ltd., Japan) Dec. 19, 1975 (Dec. 19, 1975).
Hardtmann, Goetz E. et al: “Chemistry of 2H-3, 1-benzoxazine-2,4(1H)-dione (isatoic anhydrides). 1. Synthesis of N-substituted 2H-3,1-benzoxazine-2,4(1H)-diones” Journal of Heterocyclic Chemistry., Bd. 12, Nr. 3, 1975, Seiten 565-572, XP002135866 Heterocorporation. Provo., US ISSN: 0022-152X.
Pastor, G. et al: “Synthesis of new 1H,3H-quinazoline-2,4-diones” Bulletin de la Societe Chimique de France., Bd. 5-6, Nr. 2, 1975, Seiten 1331-1338, XP002135865 Societe Francaise de Chimie. Paris., Fr ISSN: 0037-8968.
English Abstract of Hardtmann, Goetz E. et al: “Chemistry of 2H-3,1-benzoxazine-2,4(1H)-dione (isatoic anhydrides). 1. Synthesis of N-substituted 2H-3,1-benzoxazine-2,4(1H)-diones” Journal of Heterocyclic Chemistry., Bd. 12, Nr. 3, 1975, Seiten 565-572, XP002135866 Heterocorporation. Provo., US ISSN: 0022-152X.
English Abstract of Pastor, G. et al: “Synthesis of new 1H,3H-quinazoline-2,4-diones” Bulletin de la Societe Chimique de France., Bd. 5-6, Nr. 2, 1975, Seiten 1331-1338, XP002135865 Societe Francaise de Chimie. Paris., FR ISSN: 0037-8968.
English Abstract of JP 50157383 A.
English Abstract of DE 2652144 A.
English Abstract of EP 0564356 A1.
English Abstract of EP0564356A1: 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy [German][French], Dodey, Pierre et al. Jan. 4, 1992.
Bold Guido
Brüggen Jose
Ferrari Stefano
Furet Pascal
Huth Andreas
Millen White Zelano & Branigan P.C.
Novartis AG
Schering AG
Ward Paul V.
Wilson James O.
LandOfFree
Anthranilic acid amides and the use thereof as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthranilic acid amides and the use thereof as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranilic acid amides and the use thereof as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693591